跳转到主要内容
  • 认证合作伙伴
  • 关于 ELGA
    • 关于 ELGA
    • 招贤纳士
    • 活动
  • 支持
    • 实验室规划
    • 注册产品
    • Register Your Product (USA & Canada Only)
  • 联系信息
  • U.S.A.
  • U.K.
  • Deutschland
  • España
  • France
  • Italia
  • Brasil
  • 日本
首页 ELGA LabWater
  • 产品
    • PURELAB
    • CENTRA
    • MEDICA
    • BIOPURE
    • ELGA 全产品系列
  • 应用
    • 一般实验室用水要求
    • 临床生物化学
    • 免疫化学
    • 分光光度测定法:
    • 原子光谱分析法
    • 微生物分析
    • 气相色谱分析法
    • 液相色谱
    • 电化学
    • 细胞培养
    • 质谱分析法
    • 遗传学
  • 水纯化技术
    • PureSure
    • 反渗透法
    • 活性碳
    • 电去离子法
    • 离子交换法
    • 紫外线照射法
    • 过滤
  • 水中杂质
    • 微生物和细菌
    • 微粒
    • 无机化合物
    • 有机化合物
    • 溶解气体
  • Knowledge
    • 博客
    • 案例分析
    • 超纯水
    • 白皮书
  • 产品
    • PURELAB
    • CENTRA
    • MEDICA
      • Hubgrade
      • MEDICA BIOX
    • BIOPURE
    • ELGA 全产品系列
      • PURELAB® Classic
  • 应用
    • 一般实验室用水要求
    • 临床生物化学
    • 免疫化学
    • 分光光度测定法:
    • 原子光谱分析法
    • 微生物分析
    • 气相色谱分析法
    • 液相色谱
      • Hochleistungsflüssigkeitschromatographie (HPLC)
    • 电化学
    • 细胞培养
    • 质谱分析法
    • 遗传学
  • 水纯化技术
    • PureSure
    • 反渗透法
    • 活性碳
    • 电去离子法
    • 离子交换法
    • 紫外线照射法
    • 过滤
  • 水中杂质
    • 微生物和细菌
    • 微粒
    • 无机化合物
    • 有机化合物
    • 溶解气体
  • Knowledge
    • 博客
      • Analytical Chemistry
      • Clinical & Pharma
      • Cool Science
      • Environment and sustainability
      • Life in the lab
      • Purelab product design
      • Science of the future
      • Water Purity
      • Water in the lab
    • 案例分析
      • 雅培诊断的南亚团队选用 ELGA MEDICA 系统
      • Beam Me Up, Scotty: PURELAB® Option Q Delivers Essential Ultra Pure Water
      • Argenta chooses DKSH New Zealand to deliver Ultrapure water in Animal Pharma
      • Clean Water for a Clean Future
      • LS Scientific & ELGA deliver UltraPure water to the NAFDAC Laboratory
      • Lifebrain Group chooses ELGA as water partner for new modern 24/7 PCR-COVID-19 laboratory in Vienna, Austria.
      • Critital Tests Benefit from PURELAB® Option Reliable Pure Water
      • DASA:巴西最大的医疗诊断公司
      • ELGA 帮助免疫血清学实验室最大程度地增加运行时间
      • Fondazione Telethon Continues to Choose ELGA Labwater as a Trusted Partner
      • 1+ 级超纯水对非专利药物开发的重要性
      • 城市综合医院为西门子 ADVIA® 分析仪选配 MEDICA® Pro
      • Optimale Wasserqualität für mikrobiologische Forschung und Lehre
      • PURELAB® Option R Guarantees Pure Water for Leading Microfluidics Technology
      • PURELAB® Pulse Delivers Reliable Water Quality and Quantity for a Wide Range of Applications
      • PURELAB® flex:适合当今研究方法的理想培训系统
      • Powering Cutting-Edge Gene Research
      • Sichere Reinstwasserversorgung für präzise Produkttests
      • Zentrale Reinstwasser-Aufbereitung für Analyser
      • ELGA LabWater and Beckman Coulter Join Forces
      • Applied New Technologies Department Improves ICP, IC & HPLC Sample Turnaround Times with PURELAB®
      • 借助超纯水,解开南极的秘密
      • Advancing Genetic Technologies
      • Cross Infection Control: Pure and Simple
      • Researching effective new ways to prevent cardiovascular disease at the University of Columbia
    • 超纯水
    • 白皮书
      • HPLC 水纯度
      • HPLC 的制药应用
      • 降低临床风险
      • 可持续发展
  • U.S.A.
  • U.K.
  • Deutschland
  • España
  • France
  • Italia
  • Brasil
  • 日本
  • 隐私政策
  • 条款和条件
  • 全球法律合规
  • 专利
  • 页面操作员
  • 首页
  • Developing Ways to Diagnose Alzheimer’s Disease Early
Clinical & Pharma
Science of the Future

Developing Ways to Diagnose Alzheimer’s Disease Early

5 3月 2020
- by Dr Alison Halliday

Baby girl warm jacket and cap c grandfather hands in

Scientists are searching for biochemical changes in body fluids that are early indicators of Alzheimer’s disease. A new study devises a sensitive method for detecting 15 metabolites in cerebrospinal fluid, opening the door for investigating their potential as diagnostic markers.

It’s estimated that almost 47 million people worldwide are living with dementia, with numbers predicted to double every 20 years.

Alzheimer’s disease (AD) is the most common type of dementia, accounting for about two-thirds of cases in older people. A person will experience problems with memory loss and other cognitive abilities, with their symptoms developing slowly and getting gradually worse over time.

Sadly, there is no cure. But current treatments can temporarily slow down the worsening of symptoms, helping to maximize the quality of life of those affected by the disease and their caregivers for as long as possible.

Currently, there is no single definitive test that can diagnose Alzheimer’s disease. Instead, doctors will make a clinical judgment based on a series of assessments and tests that will likely include a thorough medical history, physical check-up, and memory tests, as well as brain scans or blood tests.

Benefits of Early Diagnosis of Alzheimer’s Disease

An early diagnosis of Alzheimer’s disease can provide a range of advantages, including access to the right support and treatment and precious time to plan ahead. Importantly, scientists believe that treatments will be most effective when administered early in the disease process before significant brain damage occurs.
But Alzheimer’s disease is currently difficult to diagnose when it’s in the early stages, with no established diagnostic test.

For such a test to be developed, scientists first need to identify distinctive changes in biological molecules in blood or other body fluids of people who go on to develop Alzheimer’s. The hope is that these can be developed into a reliable diagnostic test that can accurately indicate the presence of the disease before the onset of symptoms.
Disrupted biochemical pathways

Cerebrospinal fluid (CSF) could be a source of such molecules, as biochemical changes within the nervous system may be indicative of the early stages of Alzheimer’s disease. Metabolites, which are generated by the body’s metabolism, are attracting considerable attention, with alterations within CSF reported as many as several decades before the onset of symptoms.

One potential set of metabolites being studied are the polyamines, which are by-products of a biochemical pathway called the ornithine cycle. Studies have shown these are overly abundant in brain tissue samples from Alzheimer’s patients. 

A Sensitive New Analytical Technique for Early Detection of Alzheimer’s Disease

In a new study, researchers have developed a sensitive new way of enabling the detection and quantification of 15 different metabolites associated with the ornithine pathway and polyamine metabolism in CSF.(1)

The team used ultra-high-performance liquid chromatography-electrospray ionization tandem mass spectrometry (UHPLC-ESI-MS/MS) to measure these metabolites in human CSF samples. For their experiments, they used pressure-free ultra-purified water obtained using a PURELAB flex 5 system from ELGA LabWater.

This protocol sets the stage for further studies to analyze the relationship of these metabolites in the CSF of people who later go on to develop Alzheimer’s disease, with the potential to extend to the analysis of other body tissues, such as brain or blood.

Why Choose ELGA LabWater?

ELGA has been a trusted name in pure and ultrapure water since 1937. We believe in giving you choice in how you use our water purification solutions, supported by excellent service and support.


Reference:
Tsutsui, H. et al., Development of targeted metabolomics for the determination of ornithine cycle compounds as possible biomarkers in cerebrospinal fluid regarding to Alzheimer’s disease pathology using UHPLC-ESI-MS/MS. Medical Mass Spectrometry. June 2018 Vol. 2 No. 1, 1-10.
 

Dr Alison Halliday
After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.

Pure Water Essence of the Lab Whitepaper download

How well do you know your ultrapure lab water?

Do you know the most effective way to use ultrapure water, your most fundamental reagent? Read our full whitepaper and discover how you can make sure that your pure water supply delivers the performance you need to produce reliable and accurate results.

          Read the Whitepaper

 

 

  • Enquiry
  • 获取报价
  • 预订演示
  • 联系获认证的合作伙伴

Enquiry

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

获取报价

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

预订演示

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

ELGA LabWater US Headquarters

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
United Kingdom
电话: +44 (0) 203 567 7300
传真:+44 (0) 203 567 7205

Elga LabWater 总部

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
United Kingdom
电话: +44 (0) 203 567 7300
传真:+44 (0) 203 567 7205

案例研究

  • 雅培诊断
  • DASA 医学诊断
  • NeoDIN 医学研究所
  • 北斯塔福德郡 NHS 信托大学医院
  • Olsberg 职业技术学院

资源

  • 了解超纯水
  • 白皮书
  • 水纯化技术
  • 实验室应用
  • 水中杂质

Blogs

  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?
  • 语言
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • Veolia 其他站点
    • Veolia
    • Veolia Foundation
    • Veolia Water Technologies

© VWS (UK) Ltd. 以 ELGA®LabWater 的名义经营业务。2023- 保留所有权利
ELGA 是 Veolia 旗下全球实验室用水品牌。

  • 隐私政策
  • 条款和条件
  • 全球法律合规
  • 专利
  • 页面操作员
Elga Veolia
TOP

© 2017 ELGA Veolia